Exozymes Inc.
EXOZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002010788
In the last 90 days, Exozymes Inc. insiders filed 1 open-market purchase and 0 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.05M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Exozymes Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 62.9K | 124.3K | +61.4K (+97.6%) |
| Value | $471.8K | $1.05M | +$576.1K (+122.1%) |
New holders (2)
Institutions that held Exozymes Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Davidson Kahn Capital Management, LLC | 25,000 | $210.8K | 0.09% |
| Barclays PLC | 75 | $632 | 0.00% |
Sold out (0)
Institutions that held Exozymes Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.